Although the precise mechanisms underlying the down-regulation of the CYP2C19 gene were not elucidated in human HCC tissue, several mechanisms, especially epigenetic modification, such as promoter hyper-methylation of CAR might repress the expression of the CYP2C19. The gene discussed is CYP2C19; the disease is hepatocellular carcinoma.